InDex Pharmaceuticals Holding AB
STO:FLERIE
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Devon Energy Corp
NYSE:DVN
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
BlackRock Inc
NYSE:BLK
|
Financial Services
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Monster Beverage Corp
NASDAQ:MNST
|
Beverages
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.8
55.8
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Devon Energy Corp
NYSE:DVN
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
BlackRock Inc
NYSE:BLK
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Monster Beverage Corp
NASDAQ:MNST
|
US |
This alert will be permanently deleted.
InDex Pharmaceuticals Holding AB
Total Liabilities
InDex Pharmaceuticals Holding AB
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
I
|
InDex Pharmaceuticals Holding AB
STO:FLERIE
|
Total Liabilities
kr26.7m
|
CAGR 3-Years
18%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Calliditas Therapeutics AB
STO:CALTX
|
Total Liabilities
kr1.6B
|
CAGR 3-Years
85%
|
CAGR 5-Years
103%
|
CAGR 10-Years
N/A
|
||
Camurus AB
STO:CAMX
|
Total Liabilities
kr454.2m
|
CAGR 3-Years
28%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
||
S
|
Swedencare AB (publ)
STO:SECARE
|
Total Liabilities
kr2.4B
|
CAGR 3-Years
77%
|
CAGR 5-Years
152%
|
CAGR 10-Years
N/A
|
|
IRLAB Therapeutics AB
STO:IRLAB A
|
Total Liabilities
kr61.4m
|
CAGR 3-Years
40%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
||
Moberg Pharma AB (publ)
STO:MOB
|
Total Liabilities
kr24m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
InDex Pharmaceuticals Holding AB
Glance View
InDex Pharmaceuticals Holding AB engages in the development of drugs for the treatment of diseases such as inflammation and cancer. The company is headquartered in Solna, Stockholm and currently employs 6 full-time employees. The company went IPO on 2016-10-11. The firm is focused in pharmaceuticals development. The firm's drug candidate is cobitolimod that helps in ulcerative colitis treatment. In addition, the Company develops a platform of patent protected substances, DNA based ImmunoModulatory Sequences (DIMS), that helps in the treatment of various immunological diseases. The firm also offers diagnostic kit DiBiCol, which is a PCR-based method that monitors seven biomarkers specific for ulcerative colitis or Crohn’s disease from a single colonic biopsy. InDex Pharmaceuticals Holding AB operates as a parent for InDex Pharmaceuticals AB and InDex Diagnostics AB. Among the Company's shareholders are SEB Venture Capital, Industrifonden and NeoMed Management.
See Also
What is InDex Pharmaceuticals Holding AB's Total Liabilities?
Total Liabilities
26.7m
SEK
Based on the financial report for Sep 30, 2024, InDex Pharmaceuticals Holding AB's Total Liabilities amounts to 26.7m SEK.
What is InDex Pharmaceuticals Holding AB's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
-3%
Over the last year, the Total Liabilities growth was -40%. The average annual Total Liabilities growth rates for InDex Pharmaceuticals Holding AB have been 18% over the past three years , -3% over the past five years .